BGI was founded in 1999 with the vision of using genomics to benefit mankind and has since become the largest genomic organization in the world. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI has a proven track record of innovative, high profile research, which has generated over 1,000 publications, many in top-tier journals such as Nature and Science. The company also contributes to scientific communication by publishing the international research journal GigaScience.
BGI’s distinguished achievements have made a significant contribution to the development of genomics throughout the world. BGI’s goal is to make state-of-the-art genomics highly accessible to the global research community and clinical markets by integrating the industry’s broadest array of leading technologies, including BGI’s own Complete Genomics sequencing platform, economies of scale, and expert bioinformatics resources.
BGI also offers a wide portfolio of transformative genetic testing products across major diseases, enabling medical providers and patients worldwide to realize the promise of genomics-based diagnostics and personalized healthcare. BGI’s services and solutions are available in more than 50 countries around the world.
For information regarding further divisions of BGI, please visit www.genomics.cn.
Don’t hesitate to contact us to request a quote or to talk more about your requirements and how we can support your needs.
(+45) 80 300 800 (Europe)
(+1) 617 500 2741 (Americas)
(+852) 36103510 (Asia Pacific)
(＋86) 755 25273698 (China)